ヘルスとヘルスケア
迈向“精准全球化”——来自医药行业的启示
回顾我作为医生、制药行业管理者直至如今担任默克首席执行官的职业生涯，我有幸亲历了医学史上最重大的变革之一。
Belen Garijo
Appointed as Chief Executive Officer on May 1, 2026, Belén Garijo is leading Sanofi into its next phase of growth by advancing its scientific roadmap, strengthening execution, and fostering a culture of excellence. She brings deep scientific expertise and a strong track record of sustainable results at the intersection of R&D, strategy, and business model transformation.
Previously, Belén served as Chair of the Executive Board and Chief Executive Officer of Merck, holding various positions within the company since joining in 2011. Before joining Merck, she served as a Senior Vice President of Global Operations Europe at Sanofi-Aventis, where she led the integration of Genzyme following its acquisition. She has also held several leadership positions in R&D and commercial development within the healthcare sector.
Belén is a physician specializing in clinical pharmacology. She began her career as a practicing physician at La Paz Hospital in Madrid, Spain.
最新記事
ヘルスとヘルスケア
The world needs ‘precision globalization’. Pharma is showing the way
During my career as a medical doctor, pharmaceutical leader and now CEO, I’ve participated in one of the most significant revolutions in medical history.
仕事と働き方の未来
Why trust-based leadership is key to thriving in the Intelligent Age
The recent arrival of artificial intelligence (AI) and our growing ability to harness the power of data and digital technology has propelled our world from the Industrial Age into a new I...
世界経済フォーラムの取り組み
Does the future of science lie in 'bioconvergence'?
Public confidence in science and trust in scientists has rarely been higher than it is today. Worldwide, most people believe science is the best path toward a better, healthier, and more ...
金融と通貨システム
These are the 3 dimensions of resilience, according to a CEO
Have you noticed that some companies thrive while others only endure during times of change, complexity, and uncertainty? One thing makes all the difference: Resilience.
世界経済フォーラムの取り組み
Digital health can make healthcare more open, inclusive, and patient-centred. Here's how.
Over the last two decades, data and digital technologies have begun to converge with medicines, devices, and diagnostics to create a new market for digital health. The Covid-19 pandemic h...
ヘルスとヘルスケア
Schistosomiasis affects 240 million people. Here's how we can eliminate it
Neglected tropical diseases (NTDs) affect the lives of more than 1 billion people worldwide and represent an often-overlooked global health burden that translates into lost opportunities ...
ヘルスとヘルスケア
Meet the first winner of a new award for cancer research
Cancer is pervasive and does not discriminate. It was responsible for 18.1 million new cases and 9.6 million deaths worldwide in 2018, and these numbers are expected to nearly double by 2...
ヘルスとヘルスケア
ジェンダー不平等を拡大する介護の在り方を浮き彫りにした、新型コロナウイルス
新型コロナウイルスの大流行により介護の必要性が増し、予期せぬ大きな課題が提起される中、介護者を認識し、評価し、性差による偏向を減らしていくことの緊急性が高まっています。特に、リソースが限られ、患者の多くが入院できない状況において、新型コロナウイルスの患者とその家族にとって、緩和ケアおよび終末期ケアは必要性の高いものになると考えられます。
公正、多様性、包摂性
COVID-19 highlights how caregiving fuels gender inequality
The COVID-19 pandemic increases the urgency of recognizing and valuing carers and reducing gender bias because it presents enormous and unexpected challenges associated with increased car...
ヘルスとヘルスケア
What to expect from the next decade of drug development
“Change is the only constant.” These words of wisdom from the ancient Greek philosopher Heraclitus still hold true today. It is most certainly true of the pharmaceutical sector where chan...
公正、多様性、包摂性
How gender diversity at the top can boost the bottom line - and improve the world
It will take 108 years to close the overall global gender gap, according to the World Economic Forum’s 2018 Gender Gap Report. One doesn’t have to look far to see the real-world inequalit...
ヘルスとヘルスケア
This new way of understanding disease is changing medicine
A new understanding of disease biology is emerging. In a paradigm shift towards what is known as molecular pathology, medical science is increasingly looking at diseases at a molecular le...